InChI=1S/C20H32O3/c1- 2- 3- 4- 5- 6- 7- 8- 9- 12- 15- 18- 19(23- 18) 16- 13- 10- 11- 14- 17- 20(21) 22/h6- 7,9- 10,12- 13,18- 19H,2- 5,8,11,14- 17H2,1H3,(H,21,22) /b7- 6- ,12- 9- ,13- 10- /t18- ,19+/m0/s1 |
DBWQSCSXHFNTMO-QJVNBQAESA-N |
C(CCC)C/C=C\C/C=C\C[C@H]1[C@@H](C/C=C\CCCC(O)=O)O1 |
|
Mus musculus
(NCBI:txid10090)
|
See:
PubMed
|
Rattus norvegicus
(NCBI:txid10116)
|
See:
PubMed
|
Stenotomus chrysops
(NCBI:txid35579)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
PubMed
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
marine xenobiotic metabolite
Any metabolite produced by metabolism of a xenobiotic compound in marine macro- and microorganisms.
rat metabolite
Any mammalian metabolite produced during a metabolic reaction in rat (Rattus norvegicus).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
(via 8,9-EET )
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via EET )
|
|
platelet aggregation inhibitor
A drug or agent which antagonizes or impairs any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
(via EET )
anti-inflammatory drug
A substance that reduces or suppresses inflammation.
(via EET )
|
|
View more via ChEBI Ontology
Outgoing
|
(8R,9S)-EET
(CHEBI:132303)
has role
human xenobiotic metabolite
(CHEBI:76967)
(8R,9S)-EET
(CHEBI:132303)
has role
marine xenobiotic metabolite
(CHEBI:83399)
(8R,9S)-EET
(CHEBI:132303)
has role
mouse metabolite
(CHEBI:75771)
(8R,9S)-EET
(CHEBI:132303)
has role
rat metabolite
(CHEBI:86264)
(8R,9S)-EET
(CHEBI:132303)
is a
8,9-EET
(CHEBI:34490)
(8R,9S)-EET
(CHEBI:132303)
is conjugate acid of
(8R,9S)-EET(1−)
(CHEBI:131975)
(8R,9S)-EET
(CHEBI:132303)
is enantiomer of
(8S,9R)-EET
(CHEBI:132302)
|
|
Incoming
|
(8R,9S)-EET(1−)
(CHEBI:131975)
is conjugate base of
(8R,9S)-EET
(CHEBI:132303)
(8S,9R)-EET
(CHEBI:132302)
is enantiomer of
(8R,9S)-EET
(CHEBI:132303)
|
(5Z)- 7- {(2R,3S)- 3- [(2Z,5Z)- undeca- 2,5- dien- 1- yl]oxiran- 2- yl}hept- 5- enoic acid
|
(8R,9S)-EpETrE
|
ChEBI
|
(8R,9S)-epoxy-(5Z,11Z,14Z)-eicosatrienoic acid
|
ChEBI
|
(8R,9S)-epoxy-(5Z,11Z,14Z)-icosatrienoic acid
|
ChEBI
|
8(R),9(S)-EET
|
ChEBI
|
8R,9S-EET
|
LIPID MAPS
|
8R,9S-EpETrE
|
LIPID MAPS
|
8R,9S-epoxy-5Z,11Z,14Z-eicosatrienoic acid
|
LIPID MAPS
|
4697203
|
Reaxys Registry Number
|
Reaxys
|
15084647
|
PubMed citation
|
Europe PMC
|
20972997
|
PubMed citation
|
Europe PMC
|
22628547
|
PubMed citation
|
Europe PMC
|
7840649
|
PubMed citation
|
Europe PMC
|
9606961
|
PubMed citation
|
Europe PMC
|
|